| Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027) |
|---|
| 12/21/2007 | CA2835790A1 Novel process and intermediates |
| 12/21/2007 | CA2654644A1 Novel process and intermediates |
| 12/21/2007 | CA2653552A1 Industrial process for the synthesis of 17.alpha.-acetoxy-11.beta.-[4-(n,n-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 12/20/2007 | US20070292967 Assay for Ligands of the Ecdysone Receptor |
| 12/19/2007 | EP1866325A2 Novel crystalline pharmaceutical product |
| 12/12/2007 | CN101085803A Androstane compound and its preparation method and application |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 11/22/2007 | US20070270584 Process for the Preparation of Steroidal Carbothioic Acid Derivatives and Intermediates |
| 11/21/2007 | CN101076538A Steroids for cancer treatment |
| 11/07/2007 | EP1263770B1 6-oxygenated steroidal estrogens with aromatic a and b rings |
| 11/06/2007 | US7291610 Estrogenic compounds as anti-mitotic agents |
| 11/06/2007 | US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α |
| 10/31/2007 | CN101065394A process for the esterification of a carbothioic acid |
| 10/25/2007 | US20070249836 monooxygenase inhibitors; prostate cancer |
| 10/17/2007 | EP1392713B1 Liver x receptor agonists |
| 10/17/2007 | CN100343272C Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 10/04/2007 | CA2681639A1 Compounds and methods for treatment of disorders associated with er stress |
| 10/03/2007 | EP1418921B1 Anti-tumour 2-alkoxyestradiol sulfamates |
| 09/27/2007 | US20070225512 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex |
| 09/27/2007 | US20070225256 Compound |
| 09/26/2007 | CN101044155A Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 09/26/2007 | CN100339486C Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 09/19/2007 | CN100338087C Process for the production of fluticasone propionate, in particular of polymorphic form 1 |
| 09/18/2007 | CA2236648C Sulfatation of estrogen mixtures |
| 09/12/2007 | EP1832598A2 Therapeutic treatment of androgen receptor driven conditions |
| 09/07/2007 | WO2007099548A2 Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 09/07/2007 | CA2637548A1 Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 08/28/2007 | US7262023 synthesis of steroids by hydroxylation and oxidation with use of microoganisms; biosynthesis |
| 07/26/2007 | WO2007025780A3 Aldosterone receptor antagonists |
| 07/17/2007 | US7244762 Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates |
| 07/17/2007 | CA2396521C Bile compound and method of controlling behavior of lampreys therewith |
| 07/17/2007 | CA2158610C 17-deoxycorticosteroid-21-/o/-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/05/2007 | US20070155781 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 07/04/2007 | EP1802647A1 Process for the esterification of a carbothioic acid |
| 07/03/2007 | CA2133607C Corticoid -17,21-dicarboxylic esters and corticosteroid 17-caboxylic esters 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/03/2007 | CA2130943C Corticosteroid 17-alkyl carbonate 21-[o]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 06/21/2007 | US20070142345 Steroids for cancer treatment |
| 06/20/2007 | EP0973791B1 Process for the preparation of an epoxy compound |
| 06/14/2007 | US20070135400 Estradiol derivatives |
| 06/13/2007 | EP1794176A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 05/31/2007 | DE102005057408A1 New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases |
| 05/30/2007 | EP1789432A1 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abiraterone-3-esters from solution in methyl tert-butyl ether |
| 05/16/2007 | CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 05/16/2007 | CN1315864C Oxidation process for preparing the intermediate 6alpha, 9alpha-difluoro-11beta, 17alpha-dihydroxy-16.alpha-methyl-androst-1, 4-dien-3-one-17beta-carboxylic acid |
| 05/15/2007 | CA2347345C Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds |
| 05/09/2007 | EP1783221A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 05/09/2007 | EP1781683A1 Process fot the preparation of 17-0-vinyl- triflates as intermediates |
| 05/08/2007 | US7214807 Method for the preparation of fluticasone and related 17β-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
| 04/24/2007 | US7208613 Treating 17 beta -[(N,N-dimethylcarbamoyl)thio]carbonyl-6 alpha ,9 alpha-difluoro-11-beta -hydroxy-16 alpha-methyl-17-alpha -propionyloxy-3-oxoandrosta-1,4-diene with an alkali metal carbonate-alcohol system and reacting the product with bromofluoromethane |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/11/2007 | EP1771462A2 A process for the preparation of 7-alpha-alkylated 19-norsteroids |
| 04/11/2007 | EP1771461A2 Novel 2-substituted estra-1,3,5(10)-trien-17-ones used in the form of inhibitors of 17beta-hydroxysteroiddehydrogenase of type 1 |
| 03/15/2007 | US20070060746 Processes for preparation of 9,11 epoxy steroids and intermediates useful therein |
| 03/08/2007 | WO2007025780A2 Aldosterone receptor antagonists |
| 03/08/2007 | WO2006108572A3 Novel crystalline pharmaceutical product |
| 03/07/2007 | CN1923841A 7 alpha-substituted 11 alpha-hydroxysteroids and its microbiological production method |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/14/2007 | EP1539796B1 Anti-inflammatory or anti-allergic androstane complexes |
| 02/01/2007 | WO2007012228A1 Method for the preparation of fluticasone propionate |
| 02/01/2007 | US20070027128 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour |
| 01/31/2007 | CN1903872A Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds |
| 01/11/2007 | US20070010505 Methods of treating disease states using antiangiogenic agents |
| 01/10/2007 | CN1294142C 17 beta-carbothioate 17 alpha-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/10/2007 | CN1294141C 6 alpha., 9 alpha-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 01/09/2007 | US7160920 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 01/09/2007 | CA2269134C A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof |
| 01/04/2007 | WO2005077968B1 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 01/02/2007 | CA2347346C Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds |
| 01/02/2007 | CA2168850C Estrogenic compounds as anti-mitotic agents |
| 12/19/2006 | CA2149496C 11,21-bisphenyl-19-norpregnane derivatives |
| 12/14/2006 | US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 12/05/2006 | US7144877 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 12/05/2006 | US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/16/2006 | WO2005077968A8 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 11/15/2006 | EP1720894A1 Assay for ligands of the ecdysone receptor |
| 11/09/2006 | WO2006043015B1 Process for the esterification of a carbothioic acid |
| 11/07/2006 | US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/02/2006 | EP1716166A2 17-methylene- or 17-spiro-cyclopropane 7-substituted estra-1,3,5(10)-triene derivatives with anti-estrogenic activity |
| 11/02/2006 | CA2814247A1 Polymorphic and amorphous salt forms of squalamine dilactate |
| 10/31/2006 | US7129345 Keto-substituted steroid compounds |
| 10/24/2006 | US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 10/19/2006 | WO2006108572A2 Novel crystalline pharmaceutical product |
| 10/18/2006 | EP1274718B1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
| 10/11/2006 | EP1709062A1 Exemestane and its intermediates and methods of making the same |
| 10/10/2006 | US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates |
| 10/10/2006 | CA2273343C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 10/05/2006 | US20060224004 Process for preparing ursodeoxycholic acid di-sodium 3,7-disulfate |
| 10/04/2006 | CN1840539A Salangane saponin and preparation method and use thereof |
| 09/26/2006 | US7112669 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 09/21/2006 | US20060211857 6,7-Oxygenated steroids and uses related thereto |
| 09/21/2006 | US20060211670 Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates |
| 09/19/2006 | US7109187 Estrogenic compounds as anti-mitotic agents |
| 09/07/2006 | US20060198836 Method of treating hit patients with argatroban |
| 09/05/2006 | US7101866 6,9-Difluoro-17 alpha -((2-furanylcarbonyl)oxy)-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; antiinflammatory agents for the treatment of allergic conditions |
| 08/31/2006 | WO2006003013B1 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 08/31/2006 | WO2005077968A3 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 08/24/2006 | WO2006032885A3 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 08/17/2006 | US20060183727 Estrogenic compounds as anti-mitotic agents |
| 07/13/2006 | US20060154985 For therapy of prostate cancer |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |